Pay in 4 interest-free payments of $7.40 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Abbreviations CVOTs: Cardiovascular outcome trials DPP-4 inhibitors: Dipeptidyl peptidase-4 inhibitors GLP-1RA: Glucagon-like peptide-1 receptor agonists SGLT-2 inhibitors: Sodium-glucose cotransporter 2 inhibitors MACE: Major cardiovascular events RR: Risk ratio HHF: Hospitalization for heart failure References IDF Diabetes Atlas 2021 10th edition
However, the fact that insulin secretion can be restored to normal levels by administration of GLP-1 (in other words, that the beta-cell responsiveness to glucose is normalized) is clearly of considerable clinical interest and provides part of the background for the clinical use of GLP-1 receptor agonists in diabetes treatment
Serious but less common risks include pancreatitis, gallbladder problems, and kidney injury from dehydration caused by severe GI side effects
It allows glucose from food to enter cells and be used for energy
